Intellipharmaceutics International Inc. (IPCI)

[mayvid]

At least we paid off these loans!

For the three months ended May 31, 2014, net cash flows provided from financing activities of $1.0 million related principally from at-the-market issuances of 377,400 of our common shares sold on NASDAQ for gross proceeds of $1,627,659 and net proceeds to us of $1,582,898, partially offset by the repayment of the entire outstanding related party loan principal to Dr. Isa Odidi and Dr. Amina Odidi, our principal stockholders, directors and executive officers, in the amount of $0.7 million (C$0.8 million)